ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Wacker to make active for Chiesi drug

by Michael McCoy
January 15, 2018 | APPEARED IN VOLUME 96, ISSUE 3

Credit: Wacker Chemie
FDA recently inspected this Wacker plant in Halle, Germany.

Wacker Biotech will produce reteplase, the active ingredient in Retavase, for the Italian drug company Chiesi, which is relaunching the drug in the U.S. Reteplase is a recombinant nonglycosylated form of human tissue plasminogen activator used to dissolve blood clots. Wacker will produce the drug at its plant in Halle, Germany, which was recently inspected by the U.S. Food & Drug Administration. Roche previously made the active for Chiesi.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment